Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.

NCT04679571 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Decompensated Cirrhosis

Interventions

BIOLOGICAL: Albumin
DRUG: Standard Medical Treatment

Sponsor

Institute of Liver and Biliary Sciences, India